Anika Therapeutics (ANIK) Change in Intangibles (2025)

Anika Therapeutics (ANIK) reported Change in Intangibles of -$600000.0 for Q4 2025, down 200.0% quarter-over-quarter from $600000.0 in Q2 2025.

Anika Therapeutics (ANIK) Change in Intangibles (2025) Analysis & Trends

Anika Therapeutics (ANIK) has 1 years of Change in Intangibles data on file, last reported at -$600000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Anika Therapeutics 197.89 Mn 131.10 Mn 19.00 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -600,000.00
Dec 31, 2025 -600,000.00
Jun 30, 2025 600,000.00
Jun 30, 2025 600,000.00